Editor profile
Senior Editor, AI Healthcare
Elena Richter specializes in clinical AI applications, medical imaging algorithms, and AI-driven drug discovery. Her work investigates how machine learning improves diagnostic accuracy.
elena.richter@medtechdaily.orgBased on the latest report data from Future Market Insights, the global medical device market is projected to grow from USD 719.63 billion in 2026 to USD 1,288.75 billion in 2036. Behind the 6% compound annual growth rate is a synchronized restructuring of procurement logic, regional momentum, and regulatory pathways.
According to the latest Precedence Research report, the global biotechnology market size is expected to grow from $1.77 trillion in 2025 to $6.34 trillion by 2035, at a compound annual growth rate of 13.61%. AI-driven drug discovery, gene editing, and advanced biologics are becoming core growth engines.
According to a report by Healthcare Foresights, the global healthcare digital transformation market is expected to reach $270.9 billion by 2035, with a compound annual growth rate of 14.13%. AI, cloud computing, and telemedicine are accelerating the transformation of the healthcare system.
The global healthcare IT market is expected to grow from USD 246.17 billion in 2024 to USD 502.91 billion in 2035, with a compound annual growth rate of 6.71%. Telemedicine, data interoperability, and AI applications are the key drivers.
Vaymed launches SKYLINE 4 and SKYLINE 6 veterinary laser therapy systems, providing advanced Class 4 laser therapy solutions for equine rehabilitation, companion animal care, and multi-species veterinary applications.
Analyze William Blair's recent dynamics as a transaction advisor and in research coverage within the digital health and biotech sectors, interpreting capital flows and industry trends.
This article reviews the important developments in the global medical technology sector during the third week of April 2025, covering financing, FDA approvals, clinical trials, and M&A collaborations, and analyzes the impact of technological trends such as neural interfaces, AI-assisted diagnosis, and leadless pacing on the industry.
According to the report, the global wearable medical device market reached $44.5 billion in 2025, and is expected to grow to $167.8 billion by 2035, at a compound annual growth rate of 14.2%. CMS expanding reimbursement for remote monitoring, the EU's digital health strategy, and the miniaturization of biosensors are the main drivers.
Electronic health records giant Epic Systems has recently experienced a wave of senior executive departures, including President Sumit Rana and AI R&D head Seth Hain, among others. This series of personnel changes has sparked industry attention on the company's future strategy and competition in the healthcare technology talent market.
Researchers developed ALADYNOULLI, a Bayesian generative framework that jointly analyzes longitudinal electronic health records, age, and polygenic risk, identifying 21 reproducible disease features and improving disease prediction performance.
A comprehensive analysis of AI in healthcare adoption statistics for 2025-2026, covering market size, ROI, FDA clearances, and the widening gap between administrative and clinical diagnostic use.
Although smartwatch health data is becoming increasingly abundant, according to the latest survey by the American Medical Association (AMA), only 6% of doctors integrate it into their clinical workflow. Insurance reimbursement barriers, doubts about data authenticity, and difficulties in integrating with electronic health records are the main bottlenecks.
Analyze how regulatory pressure, demand explosion, and drug repurposing are reshaping R&D investment strategies and the market landscape for biopharmaceutical companies.
According to the latest survey by the ZS Impact Institute, 58% of American patients use tools like AI to research symptoms before deciding whether to seek medical care. AI is driving the transformation of the healthcare system from passive service to proactive support, but friction between patients and the system is also intensifying.
Six biomedical startups from Taiwan, led by Startup Island TAIWAN, held over 100 one-on-one business meetings with global pharmaceutical companies, investors, and research institutions at the BIO 2026 International Convention. Focusing on cutting-edge fields such as AI-assisted diagnostics, antibody therapies, and organoid platforms, this marks the continuous rise of Taiwan's international influence in the medical technology industry.
A recent survey by the ZS Impact Institute shows that 58% of American patients research their symptoms using AI or search engines before seeing a doctor, and 18% have directly used AI tools. The healthcare system is facing pressure from the transformation of patient behavior.
AbbVie acquires Apogee for nearly $11 billion, Sanofi changes leadership to address patent cliff, FDA reverses stance on gene therapy, and industry signals from BIO 2026 conference.
This week brought multiple major news in the biotechnology industry: Parabilis Medicines set a record with a $770.5 million IPO, Merck entered into a collaboration with Protillion worth up to $510 million for AI-driven drug discovery, a Lassa fever-rabies dual vaccine entered human trials, and CRISPR and mRNA delivery platforms demonstrated potential in treating cancer and Duchenne muscular dystrophy, respectively. These events reflect the accelerating convergence of capital, artificial intelligence, and gene editing technologies in medical innovation.
Medical AI is moving from single prediction to a new stage of integrating predictive and generative AI. By embedding into clinical workflows and adopting hybrid infrastructure, it helps medical institutions transform data insights into actionable clinical actions, improving patient outcomes and reducing the burden on doctors.
At the American Diabetes Association Scientific Sessions, Insulet, MiniMed, Dexcom, and Abbott showcased cutting-edge technologies including fully closed-loop insulin delivery systems, new evidence for continuous glucose monitoring, and multi-analyte sensors.